# Trial of MiStent Compared to Xience in Japan

Study · id `cardio:ct-nct02972671` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02972671](<https://clinicaltrials.gov/study/NCT02972671>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02972671

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It enrolled 120 participants.

## Technical summary

Registry record NCT02972671. Randomized; double masking; primary purpose treatment. Start 2016-11-28 (actual); primary completion 2018-04-30 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 120 participants (enrolled count; ClinicalTrials.gov record NCT02972671, source copy `cardio:ctgov-nct02972671-2020-09-04`, retrieved 2026-10-26)
- Started: 2016-11-28 (actual) (ClinicalTrials.gov record NCT02972671, source copy `cardio:ctgov-nct02972671-2020-09-04`, retrieved 2026-10-26)
- Primary completion: 2018-04-30 (actual) (ClinicalTrials.gov record NCT02972671, source copy `cardio:ctgov-nct02972671-2020-09-04`, retrieved 2026-10-26)
- Completion: 2022-04-30 (anticipated) (ClinicalTrials.gov record NCT02972671, source copy `cardio:ctgov-nct02972671-2020-09-04`, retrieved 2026-10-26)
- Countries: Japan (ClinicalTrials.gov record NCT02972671, source copy `cardio:ctgov-nct02972671-2020-09-04`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02972671-2020-09-04`, retrieved 2026-10-26)

## The registry's words

- Brief title: Trial of MiStent Compared to Xience in Japan
- Acronym: DESSOLVEJ
- Condition: Coronary (Artery); Disease
- Intervention (Device): MiStent (MT005) Coronary Artery Stent
- Intervention (Device): Xience Coronary Artery Stent
- Lead sponsor: Micell Technologies
- Lead sponsor class: INDUSTRY
- Collaborator: Cardialysis BV
- Collaborator class: INDUSTRY
- Collaborator: ClinLogix. LLC
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as the lead sponsor: Micell Technologies (`cardio:org-micell-technologies`)
- Registry lists this organization as a collaborator: Cardialysis BV (`cardio:org-cardialysis-bv`)
- Registry lists this organization as a collaborator: ClinLogix. LLC (`cardio:org-clinlogix-llc`)

## Provenance

Content hash: 52bf211f4de9a03b3c427e39db59b0c13cafffe5e445231210b235ea810a502a
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
